" /> BRAF(V600E) Kinase Inhibitor RO5212054 - CISMeF





Preferred Label : BRAF(V600E) Kinase Inhibitor RO5212054;

NCIt synonyms : B-Raf Inhibitor RO5212054;

NCIt definition : An orally available small-molecule inhibitor of mutant (V600E) v-raf murine sarcoma viral oncogene homolog B1 (BRAF) with potential antineoplastic activity. BRAF(V600E) kinase inhibitor RO5212054 selectively binds to the ATP-binding site of BRAF(V600E) kinase and inhibits its activity, which may result in an inhibition of an over-activated MAPK signaling pathway downstream in BRAF(V600E) kinase-expressing tumor cells and a reduction in tumor cell proliferation. The valine to glutamic acid substitution at residue 600 accounts for about 90% of BRAF gene mutations; the oncogenic product, BRAF(V600E) kinase, exhibits a markedly elevated activity that over-activates the MAPK signaling pathway. The BRAF(V600E) mutation has been found to occur in approximately 60% of melanomas, and in about 8% of all solid tumors.;

Molecule name : PLX3603; RO5212054;

NCI Metathesaurus CUI : CL421616;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
08/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.